Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fredun Group is an India-based healthcare and pharmaceutical group centered on Fredun Pharmaceuticals, a publicly listed formulations manufacturer and exporter. The group operates in finished-dose pharmaceuticals and has diversified into nutraceuticals, herbal and dietary supplements, diagnostic kits, and animal healthcare products. Its business appears to be commercially focused rather than R&D-led biotech, with revenue generated from manufacturing, exports, and branded or generic healthcare products across multiple international markets. Available public information indicates broad therapeutic coverage in conventional formulations such as tablets, capsules, syrups, and ointments rather than a disclosed novel-drug clinical pipeline. The group also includes affiliated businesses such as Fredun Healthcare and Fredna Enterprises.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fredun Group.